Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis.

Diabetes, Obesity & Metabolism
Lise GetherFilip K Knop

Abstract

To examine whether adults with mild to moderate atopic dermatitis (AD) had reduced insulin sensitivity and/or exhibited other gluco-metabolic disturbances compared with carefully matched healthy controls. Sixteen adult, non-obese, non-diabetic patients with mild to moderate AD and 16 gender-, age- and body mass index (BMI)-matched healthy controls underwent a hyperinsulinaemic euglycaemic clamp (insulin infusion rate: 40 mU/m2 /minute) and an oral glucose tolerance test (OGTT) with frequent blood sampling for gut and pancreatic hormones. The two groups were similar in age (33 ± 3 vs. 33 ± 3 years, mean ± standard error of the mean [SEM]), gender (56% women), BMI (24.5 ± 0.7 vs. 24.4 ± 0.7 kg/m2 ), physical activity level, fasting plasma glucose and HbA1c. Patients with AD had a mean Eczema Area and Severity Index score of 8.5 ± 1.0 (moderate disease) and a mean AD duration of 28 ± 3 years. During the OGTT, circulating glucose, insulin, C-peptide, glucagon and glucose-dependent insulinotropic polypeptide, respectively, were similar in the two groups, except glucagon-like peptide-1, which was higher in patients with AD. The clamp showed no differences in insulin sensitivity between groups (M-value 9.2 ± 0.6 vs. 9.8 ± 0.8, P = .54...Continue Reading

References

May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Aug 1, 1996·Computer Methods and Programs in Biomedicine·R HovorkaM A Young
Aug 6, 2003·Medicine and Science in Sports and Exercise·Cora L CraigPekka Oja
Sep 8, 2007·The Review of Diabetic Studies : RDS·Christos PitsavosChristodoulos Stefanadis
Jun 9, 2009·Methods in Molecular Biology·Jason K Kim
May 20, 2011·The Journal of Clinical Endocrinology and Metabolism·Ola LindgrenBo Ahrén
Oct 18, 2011·The British Journal of Dermatology·J I SilverbergM Lee-Wong
Jun 12, 2012·Lancet·Adam G TabákMika Kivimäki
Sep 3, 2013·Acta Dermato-venereologica·Sol-Britt Lonne-RahmLars-Magnus Engström
Oct 7, 2014·Indian Journal of Dermatology·Sandipan DharDeepak Parikh
Jan 13, 2015·The Journal of Allergy and Clinical Immunology·Jonathan I Silverberg, Philip Greenland
Mar 17, 2015·Journal of the American Academy of Dermatology·April Zhang, Jonathan I Silverberg
Sep 18, 2015·Lancet·Stephan Weidinger, Natalija Novak
May 18, 2016·The Journal of Investigative Dermatology·Jonathan I SilverbergRowland W Chang
Sep 18, 2016·The British Journal of Dermatology·A-S Halling-OvergaardJ P Thyssen
Feb 8, 2018·The Journal of Allergy and Clinical Immunology·Judith L ThijsDirkJan Hijnen
Feb 15, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·Z AliS F Thomsen
Oct 21, 2019·The British Journal of Dermatology·A EgebergJ P Thyssen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.